Belinostat is an inhibitor of class I histone deacetylases. Belinostat has also been used in formulation in the treatment of relapsed or refractory peripheral T cell lymphoma. Reagent-grade; for laboratory research purposes only.
Products > Antibody Drug Conjugates (ADC), Oncology API > Oncology API
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye